Full article: A therapeutic patent overview of MDM2/X-targeted therapies (2014–2018)
KEGG orthology-based annotation of the predicted proteome of Acropora digitifera: ZoophyteBase - an open access and searchable database of a coral genome – topic of research paper in Biological sciences. Download scholarly
Transposon mutagenesis identifies genes and evolutionary forces driving gastrointestinal tract tumor progression | Nature Genetics
Regulation of Tight-Junction Integrity by Insulin in an In Vitro Model of Human Blood–Brain Barrier - Journal of Pharmaceutical Sciences
Integrative Epigenetic Analysis Reveals Therapeutic Targets to the DNA Methyltransferase Inhibitor Guadecitabine (SGI‐110) in Hepatocellular Carcinoma - Liu - 2018 - Hepatology - Wiley Online Library
EA PHARMA
PDF) Synergistic Interactions of Cannabidiol with Chemotherapeutic Drugs in MCF7 Cells: Mode of Interaction and Proteomics Analysis of Mechanisms
Siremadlin (NVP-HDM201) | p53-MDM2 Inhibitor | MedChemExpress
Multi-omics analyses reveal metabolic alterations regulated by hepatitis B virus core protein in hepatocellular carcinoma cells | Scientific Reports
Tonic Inhibition by G Protein–Coupled Receptor Kinase 2 of Akt/Endothelial Nitric-Oxide Synthase Signaling in Human Vascular Endothelial Cells under Conditions of Hyperglycemia with High Insulin Levels | Journal of Pharmacology and Experimental
Cytoplasmic Tyrosine Phosphatase Shp2 Coordinates Hepatic Regulation of Bile Acid and FGF15/19 Signaling to Repress Bile Acid Synthesis: Cell Metabolism
vitamines, compléments, minéraux - Castres shopping
Ecotropic viral integration site 1, a novel oncogene in prostate cancer | Oncogene
PDF) In Vitro/In Vivo Translation of Synergistic Combination of MDM2 and MEK Inhibitors in Melanoma Using PBPK/PD Modelling: Part III
Recent Progress and Clinical Development of Inhibitors that Block MDM4/p53 Protein–Protein Interactions | Journal of Medicinal Chemistry
Loss of SHP-2 activity in CD4+ T cells promotes melanoma progression and metastasis | Scientific Reports
PDF) Active pharmaceutical ingredients based on salicylate ionic liquids: Insights into the evaluation of pharmaceutical profiles
Frontiers | Targeting the MDM2-p53 pathway in dedifferentiated liposarcoma
The NFIB‐ERO1A axis promotes breast cancer metastatic colonization of disseminated tumour cells | EMBO Molecular Medicine
EA PHARMA
